346 related articles for article (PubMed ID: 16413239)
1. Recombinant human antithrombin inhibits thrombin formation and interleukin 6 release in human endotoxemia.
Leitner JM; Firbas C; Mayr FB; Reiter RA; Steinlechner B; Jilma B
Clin Pharmacol Ther; 2006 Jan; 79(1):23-34. PubMed ID: 16413239
[TBL] [Abstract][Full Text] [Related]
2. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
Flather MD; Weitz JI; Yusuf S; Pogue J; Sussex B; Campeau J; Gill J; Schuld R; Joyner CD; Morris AL; Lai C; Théroux P; Marquis JF; Chan YK; Venkatesh G; Jessel A
Eur Heart J; 2000 Sep; 21(17):1473-81. PubMed ID: 10952840
[TBL] [Abstract][Full Text] [Related]
3. Acenocoumarol decreases tissue factor-dependent coagulation during systemic inflammation in humans.
Hollenstein U; Homoncik M; Knöbl P; Pernerstorfer T; Graggaber J; Eichler HG; Handler S; Jilma B
Clin Pharmacol Ther; 2002 May; 71(5):368-74. PubMed ID: 12011822
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and pharmacodynamics of the dual FII/FX inhibitor BIBT 986 in endotoxin-induced coagulation.
Leitner JM; Jilma B; Mayr FB; Cardona F; Spiel AO; Firbas C; Rathgen K; Stähle H; Schühly U; Graefe-Mody EU
Clin Pharmacol Ther; 2007 Jun; 81(6):858-66. PubMed ID: 17410124
[TBL] [Abstract][Full Text] [Related]
5. The effects of supra-normal protein C levels on markers of coagulation, fibrinolysis and inflammation in a human model of endotoxemia.
Spiel AO; Firbas C; Mayr FB; Leitner JM; Schmidt B; Knöbl P; Varadi K; Jilma B
Thromb Haemost; 2005 Dec; 94(6):1148-55. PubMed ID: 16411386
[TBL] [Abstract][Full Text] [Related]
6. Pharmacodynamics of active site-inhibited factor VIIa in endotoxin-induced coagulation in humans.
Jilma B; Marsik C; Mayr F; Graninger MT; Taylor FB; Ribel MC; Erhardtsen E; Handler S; Eichler HG
Clin Pharmacol Ther; 2002 Oct; 72(4):403-10. PubMed ID: 12386642
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of antiinflammatory and antiadhesive effects of heparins in human endotoxemia.
Derhaschnig U; Pernerstorfer T; Knechtelsdorfer M; Hollenstein U; Panzer S; Jilma B
Crit Care Med; 2003 Apr; 31(4):1108-12. PubMed ID: 12682480
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of reconstituted high-density lipoprotein on coagulation, fibrinolysis and platelet activation during human endotoxemia.
Pajkrt D; Lerch PG; van der Poll T; Levi M; Illi M; Doran JE; Arnet B; van den Ende A; ten Cate JW; van Deventer SJ
Thromb Haemost; 1997 Feb; 77(2):303-7. PubMed ID: 9157586
[TBL] [Abstract][Full Text] [Related]
9. Effects of IL-10 on systemic inflammatory responses during sublethal primate endotoxemia.
van der Poll T; Jansen PM; Montegut WJ; Braxton CC; Calvano SE; Stackpole SA; Smith SR; Swanson SW; Hack CE; Lowry SF; Moldawer LL
J Immunol; 1997 Feb; 158(4):1971-5. PubMed ID: 9029140
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of plasmin activity by tranexamic acid does not influence inflammatory pathways during human endotoxemia.
Renckens R; Weijer S; de Vos AF; Pater JM; Meijers JC; Hack CE; Levi M; van der Poll T
Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):483-8. PubMed ID: 14739127
[TBL] [Abstract][Full Text] [Related]
11. Effects of the pan-selectin antagonist bimosiamose (TBC1269) in experimental human endotoxemia.
Mayr FB; Firbas C; Leitner JM; Spiel AO; Reiter RA; Beyer D; Meyer M; Wolff G; Jilma B
Shock; 2008 Apr; 29(4):475-82. PubMed ID: 18598003
[TBL] [Abstract][Full Text] [Related]
12. The tumor necrosis factor alpha -308 G/A polymorphism does not influence inflammation and coagulation response in human endotoxemia.
Kovar FM; Marsik C; Cvitko T; Wagner OF; Jilma B; Endler G
Shock; 2007 Mar; 27(3):238-41. PubMed ID: 17304103
[TBL] [Abstract][Full Text] [Related]
13. Effects of anticoagulation on thrombopoietin release during endotoxemia.
Jilma-Stohlawetz P; Folman CC; von dem Borne AE; Pernerstorfer T; Hollenstein U; Knechtelsdorfer M; Eichler HG; Jilma B
J Lab Clin Med; 2001 Jan; 137(1):64-9. PubMed ID: 11150025
[TBL] [Abstract][Full Text] [Related]
14. Lepirudin blunts endotoxin-induced coagulation activation.
Pernerstorfer T; Hollenstein U; Hansen JB; Stohlawetz P; Eichler HG; Handler S; Speiser W; Jilma B
Blood; 2000 Mar; 95(5):1729-34. PubMed ID: 10688831
[TBL] [Abstract][Full Text] [Related]
15. Heparin blunts endotoxin-induced coagulation activation.
Pernerstorfer T; Hollenstein U; Hansen J; Knechtelsdorfer M; Stohlawetz P; Graninger W; Eichler HG; Speiser W; Jilma B
Circulation; 1999 Dec 21-28; 100(25):2485-90. PubMed ID: 10604885
[TBL] [Abstract][Full Text] [Related]
16. Effects of IC14, an anti-CD14 antibody, on coagulation and fibrinolysis during low-grade endotoxemia in humans.
Verbon A; Meijers JC; Spek CA; Hack CE; Pribble JP; Turner T; Dekkers PE; Axtelle T; Levi M; van Deventer SJ; Reitsma PH; van der Poll T
J Infect Dis; 2003 Jan; 187(1):55-61. PubMed ID: 12508146
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II infusion in man is proinflammatory but has no short-term effects on thrombin generation in vivo.
Ekholm M; Kahan T; Jörneskog G; Bröijersen A; Wallén NH
Thromb Res; 2009 May; 124(1):110-5. PubMed ID: 19195683
[TBL] [Abstract][Full Text] [Related]
18. Natural anticoagulants limit lipopolysaccharide-induced pulmonary coagulation but not inflammation.
Choi G; Vlaar AP; Schouten M; Van't Veer C; van der Poll T; Levi M; Schultz MJ
Eur Respir J; 2007 Sep; 30(3):423-8. PubMed ID: 17537762
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human activated protein C (rhAPC; drotrecogin alfa [activated]) has minimal effect on markers of coagulation, fibrinolysis, and inflammation in acute human endotoxemia.
Derhaschnig U; Reiter R; Knöbl P; Baumgartner M; Keen P; Jilma B
Blood; 2003 Sep; 102(6):2093-8. PubMed ID: 12750166
[TBL] [Abstract][Full Text] [Related]
20. Dobutamine does not influence inflammatory pathways during human endotoxemia.
Lemaire LC; de Kruif MD; Giebelen IA; Levi M; van der Poll T; Heesen M
Crit Care Med; 2006 May; 34(5):1365-71. PubMed ID: 16540959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
